 |
Interferon gamma-1b |
|---|---|
| Trade Name | Actimmune |
| Orphan Indication | Delaying time to disease progression in patients with severe, malignant osteopetrosis |
| USA Market Approval | USA |
| USA Designation Date | 1996-09-30 00:00:00 |
| Sponsor | Horizon Pharma Ireland Limited;Connaught House, 1st Floor, 1 Burlington Road;Dublin 4 |
